Zhejiang Wecome Pharmaceutical

Zhejiang Wecome Pharmaceutical develops and commercializes both modern traditional Chinese medicines and Western small-molecule drugs. The company has several proprietary TCM formulations on the market for gastroenteritis and oral ulcers. It also produces generic Western medicines such as roxithromycin softgels. The company operates a vertically integrated business including R&D, manufacturing across multiple dosage forms (capsules, tablets, granules), distribution chains including retail pharmacies. Clinical results are primarily related to marketed approvals of its core TCM products; no recent large-scale clinical trial data disclosed publicly.